Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 16
	QLoRA Alpha: 16.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Low BF% is associated with an increased risk of neonatal morbidity, which could be considered as evidence that it is a more sensitive measure for identifying undernutrition in newborns than birth weight percentiles. However, BF% may not be the best measure of undernutrition in all cases, particularly if there is a concurrent reduction in birth weight. Future studies should consider this limitation when evaluating the relationship between BF% and neonatal morbidity. Additionally, BF% may be influenced by gestational age, ethnicity, maternal nutritional status, and other factors; therefore, future studies should consider these confounding variables. Further work is needed to determine whether BF% is a better measure of undernutrition than birth weight percentiles or if both are required to provide a complete picture of neonatal nutrition.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The assistant's reply correctly notes that low BF% is associated with increased neonatal morbidity and that BF% could be more sensitive than birth weight percentiles. However, it is overly cautious and misses key points from the study: the ground-truth conclusion that BF% was more closely associated with morbidity than birth weight percentiles (with stronger effect size) and that BF% can identify neonates who are appropriately grown by weight but undernourished — and can exclude small neonates who are not at risk. The answer adds generic caveats about confounding and the need for further study, which are reasonable but do not substitute for directly stating the study's main finding and its practical implication.

conciseness: 0.7
Reasoning:
The assistant's reply succinctly answers the question by stating that low BF% is associated with higher neonatal morbidity and thus may be a more sensitive marker than birth weight percentiles, while appropriately noting limitations and potential confounders. It is generally concise and to the point, though it includes some cautious repetition about future studies that could be tighter.

relevance: 0.6
Reasoning:
The response is relevant and addresses the question: it correctly notes that low BF% is associated with increased neonatal morbidity and suggests BF% may be a more sensitive measure than birth weight percentiles. However, it fails to cite or quote specific findings from the provided context (e.g., the reported odds ratios or the statement that BF% was more closely associated with identifying neonates at risk and could find appropriately grown yet undernourished infants). It also hedges considerably without linking that hedging to limitations described in the study. Overall the answer is reasonable but incomplete in directly referencing the context and its explicit conclusion.

coherence: 0.8
Reasoning:
Explanation: The assistant's answer is coherent and well-structured: it directly addresses the question, states that low BF% is associated with increased neonatal morbidity and therefore may be a more sensitive indicator than birth weight percentiles, and it appropriately notes limitations and potential confounders. However, the reply is overly cautious and omits key study details (e.g., the stronger odds ratio for BF% and the finding that BF% can identify appropriately grown but undernourished neonates), and one sentence ("particularly if there is a concurrent reduction in birth weight") is unclear and may confuse the point. With those additions and a slightly firmer conclusion grounded in the reported results, the response would better match the study's conclusion.

helpfulness: 0.6
Reasoning:
The assistant's reply correctly highlights that low BF% is associated with higher neonatal morbidity and appropriately cautions about confounders and the need for further study. It is concise and acknowledges limitations. However, it is incomplete: it fails to cite the study's quantitative findings (the larger OR for BF% versus birth weight percentiles), does not state the key point that BF% can identify undernourished neonates who are appropriate-for-gestational-age (and can exclude small-but-not-at-risk neonates), and contains a somewhat unclear comment about BF% not being useful when birth weight is reduced. Overall the response is moderately helpful but misses important specifics and the main practical implication from the study.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: Endovascular revascularization and orthopaedic procedures were successful in saving most feet from major amputation. The indication for the procedure should be based on the presence of a critical limb ischemia and a Charcot foot. The duration of treatment is longer than expected. This observation should be considered when designing further prospective studies. The use of endovascular revascularization and orthopedic procedures in patients with Charcot foot seems to have an acceptable outcome. However, these results should be confirmed by other centers. Further studies should focus on the long-term follow-up of this type of pathology.
It seems that the best treatment for ischemic Charcot neuroarthropathy is still unknown and it requires further investigation. This study suggests that there may be no single "cure" for this disease. It would be advisable to consider the severity of the disease and its progression before deciding on the treatment approach. We recommend a multidisciplinary approach including vascular surgeons, orthopedic surgeons, podiatrists and endocrinologists. It is also important to include a rehabilitation program after treatment. Further studies should focus on the efficacy and safety of these treatments. A randomized prospective study comparing treatment strategies in patients with severe ischemic Charcot neuroarthropathy is needed.
(i) The use of endovascular revascularization and orthopedic procedures for patients with Charcot foot seems to have an acceptable outcome. These results should be confirmed by other centers. Future studies should focus on the long-term follow-up of this type of pathology. (ii) The treatment of ischemic Charcot neuroarthropathy is still controversial and requires further investigation. We propose a multidisciplinary approach. (iii) The duration of treatment is longer than expected. Therefore, we suggest that the follow-up period should be longer than the standard 3 months. (iv) There is no consensus about the indications for surgery. A prospective study is needed to define the indications for each treatment strategy.
The main issue with ischemic Charcot neuroarthropathy is the risk of lower extremity amputation. Most patients had a good result with the use of endovascular revascularization and orthopedic procedures, but only a few patients required below knee amputation. The decision to perform an amputation should be taken by a multidisciplinary team. The use of endovascular revascularization and orthopedic procedures has the advantage of reducing the need for major amputations, but these results must be confirmed by other centers.
(i) A multidisciplinary approach including vascular surgeons, orthopedic surgeons, podiatrists and endocrinologists is recommended. (ii) The use of endovascular revascularization and orthopedic procedures is associated with a low complication rate. (iii) Patients with Charcot foot should receive a rehabilitation program after treatment. (iv) The duration of treatment is longer than expected. Therefore, it is necessary to extend the follow-up period beyond the standard 3 months.
We observed a high success rate of limb salvage and a short healing time after endovascular revascularization and orthopedic correction. However, the duration of treatment is longer than expected. Further studies are warranted to confirm these

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
The assistant’s reply generally aligns with the ground truth: it recognizes that ischemic Charcot neuroarthropathy benefits from revascularization alongside surgical/orthopedic care, that a multidisciplinary approach is appropriate, and that limb salvage is achievable. However the reply is repetitive, lacks a clear direct answer to whether ischemic Charcot is a distinct entity requiring different treatment (it implies this but does not state it explicitly), and contains a factual inconsistency ("short healing time" versus multiple statements that treatment duration is prolonged and the reported mean healing time ≈197 days). Overall the content is largely correct but imprecise and poorly organized.

conciseness: 0.3
Reasoning:
The response is verbose and highly repetitive, restating the same points multiple times without a clear, concise answer to the question. It conveys relevant information (endovascular revascularization plus orthopedic treatment can achieve high limb-salvage rates and longer healing times) but fails to directly and succinctly state that ischemic Charcot foot represents a distinct presentation that often requires revascularization to support surgical/orthopedic management. It also contains duplicated bullet-like items and an unfinished final sentence, reducing clarity and concision.

relevance: 0.5
Reasoning:
The assistant's reply is broadly relevant: it addresses whether ischemic Charcot foot requires different management by emphasizing the role of endovascular revascularization, multidisciplinary care, and longer treatment/follow-up. However, it fails to cite or quote specific results from the provided context (for example, the reported 90% limb salvage and mean healing time ~197 days), is repetitive, and contains a contradictory statement (“short healing time”) that conflicts with the context's finding of prolonged healing. Overall it answers the question qualitatively but does not explicitly ground claims in the study data.

coherence: 0.4
Reasoning:
The response is only partially coherent. It presents relevant points (endovascular revascularization with surgical/orthopedic care can salvage limbs; a multidisciplinary approach and longer follow-up are advisable) and is organized into conclusions and recommendations. However it is repetitive, contains internal contradictions (e.g., stating both "short healing time" and that treatment is "longer than expected"), and does not directly and succinctly answer whether ischemic Charcot foot is a distinct entity requiring different treatment. Overall the structure is uneven and the message is muddled by redundancy and inconsistency.

helpfulness: 0.4
Reasoning:
The assistant's reply is only partially helpful. It correctly emphasizes that endovascular revascularization plus orthopedic/surgical care and a multidisciplinary approach can salvage limbs in ischemic Charcot neuroarthropathy and that further study and longer follow-up are needed. However, the answer is repetitive, unfocused, and contains a contradictory sentence about "short healing time" despite elsewhere noting prolonged treatment; it also fails to clearly state that ischemic Charcot is a distinct clinical scenario that generally requires revascularization in addition to standard Charcot care, and it does not cite or summarize the study's key results (90% limb salvage, mean healing ~197 days). Overall the response gives appropriate general recommendations but lacks clarity, precision, and use of the provided data.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: There is no indication to select radical hysterectomy as a preferred treatment option in patients with endometrial cancer who have suspected cervical involvement. In this multicenter retrospective study, there were no significant differences in clinicopathological factors or oncologic outcomes among the three different types of surgery performed in patients with endometrial adenocarcinoma who had suspected gross cervical involvement. Further, RH was associated with longer operative times, higher rates of blood transfusions, and increased risk of severe urinary complications. These results suggest that mRH and SH may be reasonable alternatives to RH in these patients. However, further prospective studies are warranted to confirm our findings and to determine optimal management strategies for these patients.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.9
Reasoning:
The assistant's answer accurately and concisely reflects the key findings of the GOTIC-005 study: type of hysterectomy was not an independent prognostic factor for survival or recurrence, radical hysterectomy offered no survival benefit, and RH was associated with longer operative time and higher rates of transfusion and urinary complications. The recommendation that mRH and SH may be reasonable alternatives and that prospective studies are needed is an appropriate, cautious interpretation. A minor omission is that the reply did not explicitly list the prognostic factors that were identified (age, grade, peritoneal cytology, lymph node involvement), but this does not affect the overall correctness.



conciseness: 1.0
Reasoning:
The assistant's reply is concise and on point: it accurately states that radical hysterectomy (RH) showed no survival benefit, summarizes the lack of differences in oncologic outcomes across surgery types, highlights the higher perioperative and urinary complications with RH, and appropriately calls for prospective confirmation. It omits mention of the other prognostic factors identified in the study (age, grade, peritoneal cytology, lymph node involvement), but that detail was not essential to answer whether RH is needed.

relevance: 1.0
Reasoning:
The assistant's reply accurately and concisely summarizes the GOTIC-005 study findings: it states that radical hysterectomy showed no survival benefit compared with modified or simple hysterectomy and correctly notes the greater operative time, transfusion rates, and urinary complications associated with RH. It therefore directly answers the question and reflects the key conclusions from the provided context; the only minor limitation is the lack of specific numerical results or statistical values, but that does not affect relevance.

coherence: 0.9
Reasoning:
The assistant's reply is clear, well-structured, and directly addresses the study question. It accurately summarizes the main findings (no survival benefit or prognostic effect of hysterectomy type, greater operative morbidity with RH) and gives an appropriate, cautious conclusion that modified or simple hysterectomy may be reasonable alternatives while calling for prospective studies. Minor omissions (e.g., explicit mention of sample size and follow-up duration) do not undermine coherence.

helpfulness: 0.9
Reasoning:
The assistant's reply accurately and concisely conveys the study's main conclusions: radical hysterectomy (RH) showed no oncologic benefit over modified or simple hysterectomy, RH had greater operative morbidity (longer operative time, more transfusions, worse urinary complications), and further prospective study is warranted. It is helpful and appropriate for the question asked; a minor omission is lack of explicit mention that hysterectomy type was not an independent prognostic factor on multivariate analysis and not citing sample size/follow-up, but these are small details relative to the main findings.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Pancreaticoduodenectomy is one of the most complex abdominal surgeries, and readmissions following PD are associated with increased morbidity and mortality. This study highlights the importance of optimizing patient care during the index admission and the need for further investigation into the etiology of readmissions. Identifying and addressing potential risk factors will be critical to improve outcomes after PD. The following areas may require attention to reduce the number of readmissions:

1. Optimize perioperative care: The use of multivisceral resection and prolonged length of stay in the intensive care unit or hospital should be reevaluated.
2. Pancreatic fistulas: These are a major cause of readmissions. Strategies to minimize pancreatic fistula formation include better surgical technique, meticulous suturing, and appropriate use of pancreaticogastrostomy.
3. Wound complications: Delayed closure of anastomoses or wounds and the presence of pneumonia, sepsis, or other infections could lead to readmission. Proper wound management and timely antibiotics might help reduce readmissions.
4. Ileus and delayed gastric emptying: Postoperative ileus can contribute to readmissions. Techniques such as bowel irrigation and bowel preparation may help reduce this risk.
5. Timely postdischarge care: Early postoperative care and close monitoring of patients discharged home are crucial. Patients requiring additional treatment or who experience complications may benefit from early intervention.
6. Preventing readmissions due to intra-abdominal hemorrhage: Avoiding unnecessary exposure to radiation and minimizing blood loss during PD will help decrease the likelihood of bleeding and subsequent readmissions.
7. Improving patient education: Lack of knowledge about proper wound care, dietary instructions, and medications may result in readmissions. Educating patients and their families properly before discharge may help prevent readmissions.
8. Multidisciplinary care: Collaboration among surgeons, nurses, and other specialists involved in patient care may help identify high-risk patients and develop strategies to prevent readmissions.
9. Standardization of protocols: Adopting uniform protocols for PD can help identify potential issues before they become problems and reduce variability in patient care.
10. Evaluating and refining current practices: Periodically reviewing and updating the clinical practice guidelines based on available evidence will help optimize outcomes after PD.

These findings highlight the need for further research into optimal patient selection and the development of new techniques to reduce readmissions. By optimizing perioperative care, minimizing potential complications, and improving patient education, hospitals can strive toward reducing readmissions rates after PD.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.5
Reasoning:
The assistant correctly identifies key predictors from the study—pancreatic fistula and more complex (multivisceral) resections, and it sensibly emphasizes optimizing perioperative care, multidisciplinary care, patient education, and closer postdischarge monitoring. However, the reply misses a central factual point from the ground truth: that about half of readmissions occur very early (≤7 days) and that efforts should be centered on preventing these early readmissions. It also includes several speculative or imprecise recommendations (e.g., advocating pancreaticogastrostomy as a general solution, suggesting bowel irrigation/preparation to prevent ileus, and mentioning "avoiding unnecessary exposure to radiation" to prevent intra‑abdominal hemorrhage) that are not supported by the presented data and reduce the answer’s accuracy and focus.

conciseness: 0.3
Reasoning:
The response is wordy and lists many broad, sometimes non-specific interventions rather than succinctly summarizing the study's key findings and targeted implications. It fails to clearly state the two main independent predictors (complex/multivisceral resection and pancreatic fistula) and that half of readmissions occur within 7 days — points that would directly guide prevention efforts — so it is not concise or focused.

relevance: 0.7
Reasoning:
The assistant's reply addresses the question by offering prevention strategies and does reference real factors from the context (pancreatic fistula, multivisceral resection, prolonged length of stay and ICU admission) that were independently associated with readmission. However it omits the specific, important finding that roughly half of readmissions occur within 7 days and that preventing early readmissions should be a focus. It also includes some recommendations not supported or mentioned in the provided context (e.g., pancreaticogastrostomy as a specific mitigation, bowel irrigation for ileus, "avoiding unnecessary exposure to radiation") and some wording that blurs distinctions in the data (e.g., conflating ICU use and prolonged hospital stay without quoting the exact associations). Overall the response is relevant and partly grounded in the excerpt but misses a key conclusion and includes a few peripheral or unsupported suggestions.

coherence: 0.6
Reasoning:
The response is generally coherent and well-structured: it gives a clear list of actionable areas (perioperative care, pancreatic fistula prevention, postdischarge monitoring, multidisciplinary care, patient education, protocol standardization) that address how readmissions after PD might be reduced. It correctly highlights pancreatic fistula and procedure complexity as important contributors. However, it fails to explicitly note the study's key finding that half of readmissions occur within 7 days and that efforts should especially target preventing early readmissions. A few recommendations are vague or questionable (e.g., "avoiding unnecessary exposure to radiation" to prevent hemorrhage, bowel irrigation for ileus), and several suggestions are general rather than directly tied to the study's specific results.

helpfulness: 0.4
Reasoning:
The assistant's reply offers a broad, practical list of strategies (perioperative optimization, patient education, multidisciplinary care, standardization) that are generally helpful for reducing readmissions. However, it fails to highlight the study's key, evidence-based findings: that complexity of the initial resection (multivisceral resection) and pancreatic fistula were independent predictors of readmission, and that half of readmissions occur within 7 days — therefore efforts should particularly target preventing early readmissions. The answer also includes some questionable or unsupported recommendations (for example, recommending pancreaticogastrostomy as a general fix, proposing bowel irrigation/preparation to prevent ileus, and suggesting "avoiding unnecessary exposure to radiation" to prevent intra-abdominal hemorrhage), which are either overly specific without evidence or not clearly related to the study data. Overall the response is moderately useful but incomplete and contains some inaccurate or unsubstantiated suggestions.

================================================================================
Average correctness Score: 0.55
Average conciseness Score: 0.565
Average relevance Score: 0.575
Average coherence Score: 0.615
Average helpfulness Score: 0.53
